Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9023
|
pubmed:dateCreated |
1996-9-6
|
pubmed:abstractText |
Effective antimicrobial therapy can reduce the duration and volume of cholera diarrhoea by half. However, such treatment is currently limited by Vibrio cholerae resistance to the drugs commonly prescribed for cholera, and by the difficulties involved in the administration of multi-drug doses under field conditions. Because of its favourable pharmacokinetics we thought it likely that single-dose ciprofloxacin would be effective in the treatment of cholera.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
3
|
pubmed:volume |
348
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
296-300
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8709688-Administration, Oral,
pubmed-meshheading:8709688-Adult,
pubmed-meshheading:8709688-Cholera,
pubmed-meshheading:8709688-Ciprofloxacin,
pubmed-meshheading:8709688-Double-Blind Method,
pubmed-meshheading:8709688-Doxycycline,
pubmed-meshheading:8709688-Humans,
pubmed-meshheading:8709688-Male,
pubmed-meshheading:8709688-Middle Aged,
pubmed-meshheading:8709688-Treatment Outcome,
pubmed-meshheading:8709688-Vibrio cholerae
|
pubmed:year |
1996
|
pubmed:articleTitle |
Randomised controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae 01 or 0139.
|
pubmed:affiliation |
International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|